GENEVA--(BUSINESS WIRE)--Unilabs, one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services, announced further growth today, reporting that for the quarter ending 30 September 2015, revenue was €152.8m, compared to €141.7m in Q3 2014. The results show a significant and positive organic sales growth of 4.5% (CER†) leading to EBITDA growth vs Q3 2014 of 14.1%. This marks the 5th successive quarter of revenue growth, EBITDA growth and cost savings.
Help employers find you! Check out all the jobs and post your resume.
